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responsibility of XAbstract The binding characteristics of indigotin with human serum albumin (HSA) and bovine
serum albumin (BSA) have been investigated by various spectroscopic techniques. Spectroscopic
analysis revealed that the quenching mechanism between indigotin and HSA/BSA belonged to the
static quenching. The displacement experiments suggested that indigotin primarily bound to
tryptophan residues on proteins within site I. The thermodynamic parameters indicated that the
binding of indigotin–HSA/BSA mainly depended on the hydrophobic interaction. The binding
distance of indigotin to HSA/BSA was evaluated. The results by synchronous ﬂuorescence, three-
dimensional ﬂuorescence, Fourier Transform Infrared spectroscopy (FT-IR) and circular dichroism
(CD) spectra showed that the conformation of proteins altered in the presence of indigotin.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Indigotin (Fig. 1) is one of the oldest natural dyes, which has
been obtained from a wide variety of plants such as Indigofera
spp. (Africa, Asia and South America), Polygonum tinctoriumersity. Production and hosting by E
.004
2568067;
(Z.-J. Cheng)
i’an Jiaotong University.(China and Korea) and Isatis tinctoria (Europe) [1]. It has
been widely used as colorant in common foods such as sweets,
drinks and ice cream. Like many other food additives, control
the dosage of indigotin is of considerable importance in food
industry because of its toxic and carcinogenic potential [2].
It was reported that some dyes would stain certain tissues;
however, these dyes would selectively stain, combine with and
destroy pathogenic organisms without causing appreciable
harm to the host [3]. Nowadays, much research on the binding
of drugs to proteins has been carried out [4–11], but seldom
report on the binding interactions of proteins with dyes. The
study of the interaction between indigotin and proteins was
not only important to comprehend its transport and metabo-
lism process in the body, but also it could help us know thelsevier B.V. All rights reserved.
Fig. 1 Molecular structures of indigotin.
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especially at lower concentrations.
Serum albumins (SAs) are the major soluble protein
constituents of the circulatory system, and constitute
50–60% of total amount of plasma proteins [12]. The most
important property of this group of proteins is that they serve
as transporters for a variety of compounds such as drugs, fatty
acids and amine-terminated dendrimers [13]. In this work,
bovine serum albumin (BSA) and human serum albumin
(HSA) were selected as the models for evaluating the interac-
tions of dyes with proteins because of their similar folding and
well-known primary structure [11]. From the spectroscopic
point of view, one of the main differences between the two
proteins is that HSA has only one tryptophan residue (Trp-
214) in sub-domain IIA, whereas BSA has two tryptophan
residues (Trp-134 and Trp-212), that is to say, Trp-134 in the
ﬁrst domain is located on the surface of the molecule, and Trp-
212 in the second domain is located within a hydrophobic
binding pocket of BSA [14]. Because investigation on the
interactions between dyes and proteins can help us better
understand the absorption and distribution of dyes, it would
become an important research ﬁeld in chemistry, life sciences
and clinical medicine.
In the paper, the binding interactions of indigotin to BSA/
HSA have been investigated by various spectroscopic meth-
ods. The binding constants, the thermodynamic parameters,
the number of binding sites, the binding forces and the energy
transfer distance of indigotin–BSA/HSA complexes were
estimated. At the same time, the effect of indigotin on the
microenvironment and conformation of proteins was also
discussed. In addition, the binding mechanism of indigotin
with proteins was analyzed, and the effects of common ions on
the binding constants of indigotin–BSA/HSA complexes were
explored.2. Materials and methods
2.1. Reagents and chemicals
Human serum albumin (HSA, 96% purity) acquired from
Sigma chemical company (St. Louis, USA), and bovine serum
albumin (BSA, Fraction V, 98% purity) purchased from
Roche Company, were used without further puriﬁcation,
and they were both dissolved in the Tris–HCl buffer solution
(pH 7.4) to form a solution of 2.0 104 M and then stored in
the dark at 4 1C; Indigotin (98% purity) was purchased from
Aladdin Chemistry Co., Ltd. (Shanghai, China) and its stock
solution was prepared by dissolving it in doubly distilled water
with the ﬁnal concentration of 6.0 104 M; Phenylbutazone
(99þ% purity) was purchased from ACROS ORGANICS
(New Jersey, USA); Ibuprofen (99% purity) was purchasedfrom Shanghai Civi Chemical Technology Co., Ltd. (Shang-
hai, China); Digitoxin (99% purity) was purchased from
Hubei Huabei Biomedicine Co., Ltd. (Wuhan, China). All
other materials were of analytical reagent grade and doubly
distilled water was used throughout the experiment.2.2. Spectroscopic measurements
All ﬂuorescence spectra were carried out on a Cary Eclipse
ﬂuorescence spectroﬂuorometer (Varian, USA) equipped with
a xenon lamp source and 1.0 cm quartz cell and a thermostat
bath. 3.0 mL of BSA/HSA solution was added accurately into
the quartz cell and then titrated by the successive additions of
indigotin solution with the concentration of 6.0 104 M
using a 50 mL microsyringe to attain a series of ﬁnal concen-
trations. Titrations operated manually and mixed moderately.
The ﬂuorescence spectra were recorded in the range of
250–500 nm (excitation wavelength 280 nm) using 5/5 nm slit
widths at different temperatures (293, 298, 304 and 310 K).
Synchronous ﬂuorescence spectra were recorded from 220 to
320 nm at Dl¼15 and Dl¼60 nm, respectively. In addition,
the ﬂuorescence spectra of indigotin–BSA/HSA systems were
also determined in the presence of some common ions (such as
Ca2þ, Zn2þ, Mn2þ, Fe3þ, Cu2þ, Cl, CH3COO
 and CO3
2) in
the range of 250–500 nm at 298 K. Also appropriate blanks
corresponding to the buffer were subtracted to correct the
ﬂuorescence background.
The competitive experiments between indigotin and three
site markers (ibuprofen, phenylbutazone and digitoxin) for
BSA/HSA were performed using the ﬂuorescence titration
method. The concentrations of BSA, HSA and the site marker
were all stabilized at 5.0 106 M. The solution of indigotin
was gradually added into the BSA-ibuprofen, BSA-phenylbu-
tazone, BSA-digitoxin, HSA-ibuprofen, HSA-phenylbutazone,
or HSA-digitoxin mixtures. The ﬂuorescence quenching data
for six systems were recorded in the range of 250–500 nm using
an excitation wavelength of 280 nm.
UV–vis absorption spectra were collected on a UV-3600
spectrophotometer (Shimadzu, Japan) equipped with 1.0 cm
quartz cells at 298 K. And UV–vis absorption spectra of BSA/
HSA in the presence and absence indigotin were recorded in
the range of 230–500 nm. The concentration of BSA/HSA was
ﬁxed at 5.0 mM while those of indigotin changed from 0 to
10.0 mM.
FT-IR measurements were carried out on a Nicolet Nexus
6700 FT-IR spectrometer (America) via the attenuated total
reﬂection (ATR) at a resolution of 4 cm1 and 64 scans. FT-IR
spectra of HSA (0.10 mM) and BSA (0.10 mM) in the presence
and absence of indigotin were recorded in the range of
400–4000 cm1 at 298 K. The molar ratio of dye/protein
was maintained at 3:1. The corresponding absorbance con-
tributions of the buffer and indigotin solutions were recorded
and digitally subtracted with the same instrumental para-
meters.
Three-dimensional ﬂuorescence spectra were performed
under the following conditions: the initial excitation wave-
length was set at 200 nm with increment of 2 nm, the number
of scanning curves was 76; the emission wavelength was
recorded between 200 and 500 nm at a scanning rate of
24000 nm/min, and other scanning parameters were the same
as those of the ﬂuorescence quenching spectra.
Investigation of interaction between indigotin and serum albumins 259CD spectra of BSA/HSA in the absence and presence of
indigotin were performed on a Jasco-810 automatic recording
spectropolarimeter (Japan) using a 0.1 cm cell at room
temperature. All the CD spectra were recorded in the range
of 200–260 nm at a scanning rate 100 nm/min. Spectra were
corrected for buffer absorbance and recorded at the molar
ratio of proteins/dye of 1:10 and 1:20.3. Results and discussion
3.1. The binding mechanism analysis of indigotin and
HSA/BSA
Fluorescence spectroscopy has been widely applied to inves-
tigate the interactions of drugs to proteins, and hence it can be
used to analyze the quenching mechanism of proteins-drugs
complexes. The ﬂuorescence spectra of BSA/HSA in the
presence of indigotin are shown in Fig. 2. As shown in
Fig. 2, the ﬂuorescence intensities of BSA/HSA decreased
with increasing the concentrations of indigotin, indicating the
strong interactions between indigotin and BSA/HSA occurred
[15]. From latter UV–vis absorption, ﬂuorescence, FT-IR, 3D
ﬂuorescence and CD spectra, we could conclude that the
indigotin–BSA and indigotin–HSA complexes were formed
and the binding interactions affected the conformation of
proteins.
Fluorescence quenching can proceed by different mechan-
isms, which are usually classiﬁed as either dynamic quenchingFig. 2 Fluorescence spectra of BSA (A) and HSA (B) in the presence
c(indigotin) (mM), 1–9: 0, 2.0, 4.0, 6.0, 8.0, 10.0, 12.0, 14.0 and 16.0
T¼298 K.
Table 1 The parameters of Stern–Volmer plots for the indigotin
T (K) BSA–indigotin
Ksv ( 105 L/mol) Kq ( 1013 L/(mol s)) R
293 1.106 1.106 0.9988
298 1.013 1.013 0.9920
304 0.990 0.990 0.9856
310 0.915 0.915 0.9910or static quenching. For the dynamic quenching, as the
temperature of the system rises, the effective collision time
between molecules, the energy transfer efﬁciency and the
ﬂuorescence quenching constants of substances will all
increase [16]. Whereas, for the static quenching, increasing
temperature reduces the stability of complexes formed, result-
ing in the quenching constants decrease. In order to examine
the quenching mechanism, we ﬁrst assumed that the ﬂuores-
cence quenching was a dynamic quenching, thus the ﬂuores-
cence quenching data were analyzed by the Stern–Volmer
equation [17]:
F0=F ¼ 1þ Ksv½Q ¼ 1þ Kqt0½Q ð1Þ
where F0 and F denote the steady-state ﬂuorescence intensities
in the absence and presence of quencher, respectively. Ksv, Kq,
t0 and [Q] are the Stern–Volmer quenching constant, the
quenching rate constant of biomolecule, the average lifetime of
protein without the quencher, and the concentration of
quencher, respectively. The values of Ksv could be calculated
by linear regression of a plot of F0/F versus [Q]. Obviously,
Kq ¼Ksv=t0 ð2Þ
Taking the ﬂuorescence lifetime of the biopolymer (t0) as
around 108 s [16], the values of Kq could be obtained
according to Eq. (2).
The insets of Fig. 2 display the Stern–Volmer plots for the
quenching of BSA/HSA by indigotin at 298 K. The values
of Ksv, Kq and R at four different temperatures (293, 298, 304of various concentrations of indigotin, c(BSA)¼c(HSA)¼5.0 mM;
, respectively. The insets correspond to the Stern–Volmer plots.
–BSA/HSA systems at different temperatures.
HSA–indigotin
Ksv ( 105 L/mol) Kq ( 1013 L/(mol s)) R
1.135 1.135 0.9865
1.056 1.056 0.9894
0.960 0.960 0.9874
0.840 0.840 0.9871
Z.-J. Cheng et al.260and 310 K) are listed in Table 1. As shown in Table 1, the
values of Ksv decreased with increasing temperature. More-
over, the values of Kq were far greater than the maximum
scattering collision quenching constant value of the biomole-
cule (2 1010 L/(mol s)) [18]. The results indicated that the
quenching mechanism of indigotin–BSA/HSA was initiated by
the complex formation rather than the dynamic collision. In
addition, the quenching data were further analyzed by the
static quenching equation [19]:
F0=ðF0FÞ ¼ 1=fa þ 1=Kafa½Q ð3Þ
In the present case, (F0F) is the difference in ﬂuorescence
intensities between the absence and presence of quenching com-
pound at the concentration [Q], Ka is the effective quenching
constant for the accessible ﬂuorophores, and fa is the fraction of
accessible ﬂuorophore to a polar quencher, which indicates the
fractional ﬂuorescence contribution of the total emission for an
interaction with a hydrophobic quencher. The plots of F0/(F0F)
versus 1/[Q] yield 1/fa as the intercept, and 1/faKa as the slope
(Fig. 3). Thus, the ratio of the intercept and the slope gives the
value of Ka. The corresponding Ka values for the indigotin–BSA
complex were obtained to be 9.579 104 L/mol, at 293 K;
8.731 104 L/mol, at 298 K; 7.613 104 L/mol, at 304 K;
5.204 104 L/mol, at 310 K. The values of Ka for the indigotin–
HSA complex were obtained to be 7.645 104 L/mol, at 293 K;
5.842 104 L/mol, at 298 K; 5.117 104 L/mol, at 304 K;
2.886 104 L/mol, at 310 K. The decreasing trend of the Ka values
with increasing temperature was in accordance with theFig. 3 Modiﬁed Stern–Volmer plots for BSA (A) and HSA (B) wit
Table 2 The parameters of Stern–Volmer plots for the indigot
T¼298 K.
T (K) Indigotin–BSA
[BSA] ( 106 M) Ksv ( 105 L/mol) R
298 3.0 1.743 0.9854
5.0 1.013 0.9920
7.0 0.799 0.9872dependence Ksv values on temperature as mentioned above.
Therefore, the result reconﬁrmed that the quenching mechanism
between indigotin and BSA/HSA belonged to the static quenching.
Besides, ﬂuorescence quenching mechanism can be also
conﬁrmed by the analysis of Stern–Volmer plots at different
concentrations of proteins. The value of Ksv is expected to
depend on the concentration of BSA/HSA in a static quenching
process, and yet its value does not change at any concentration
of BSA/HSA in only a dynamic process [20]. The plots of F0/F
versus [Q] yield Ksv as the slope (not show the ﬁgure). The
corresponding values of Ksv and R for indigotin–BSA/HSA
complexes are shown in Table 2. It could be seen from Table 2
that the values of Ksv decreased with increasing the concentra-
tions of proteins for two systems. The results suggested that the
quenching mechanism of BSA–indigotin and HSA–indigotin
systems was initiated by the static quenching.3.2. UV–vis absorption spectra
UV–vis absorption measurement is a very simple and effective
method, which is often applied to explore the structural changes of
protein and investigate the ligand-protein complex formation.
Indigotin (Fig. 4) showed a strong absorption around 280 nm,
overlapping with proteins. Upon addition of indigotin into serum
albumins solution, the peak at 280 nm was gradually increased.
Since both indigotin and proteins have absorption at 280 nm, it is
unable to predict whether the increase in the absorption might be
due to the interaction between the molecules or to increase in the
concentration of indigotin. As a consequence of this fact, we haveh indigotin at (’) 293 K, (&) 298 K, (m) 304 K and (O) 310 K.
in–BSA/HSA systems at different concentrations of proteins,
Indigotin–HSA
[HSA] ( 106 M) Ksv ( 105 L/mol) R
3.0 2.992 0.9863
5.0 1.056 0.9894
7.0 0.945 0.9911
Fig. 4 UV–vis absorbance spectra of [BSA–indigotin complex][indigotin] (A) and [HSA–indigotin complex][indigotin] (B); the
concentrations of BSA and HSA were kept at 5.0 mM (a); the indigotin concentrations for two systems were maintained at 2.00 mM
(b), 4.00 mM (c), 6.00 mM (d), 8.00 mM (e) and 10.00 mM (f); a concentration of 2.00 mM (g) was used for indigotin only.
Fig. 5 Plots of log [(F0F)/F] versus log [Q] for the BSA–indigotin (A) and HSA–indigotin (B) systems at four different temperatures,
cBSA¼cHSA¼5.0 mM, pH¼7.4.
Investigation of interaction between indigotin and serum albumins 261recorded UV absorption spectra of indigotin, free BSA/HSA and
[indigotin–BSA/HSA complex][ indigotin] systems (Fig. 4).
As could be seen from Fig. 4, the absorption intensities of BSA/
HSA increased with the addition of indigotin and the maximum
peak position of the indigotin–BSA/HSA systems red shifted
(from 278 to 281 nm), which indicated that indigotin could bind to
proteins and the indigotin–BSA/HSA complexes were formed and
in the polarity around the tryptophan residues altered [21].
3.3. The binding parameters and binding interaction force of
BSA/HSA with indigotin
If we assume that there are independent binding sites in the
biomolecule, the binding constant (K) and the number of
binding sites (n) can be calculated using the equation shown
below [22]:
log½ðF0FÞ=F  ¼ logK þ nlog Q½ ð4Þ
where F0, F, and [Q] are the same as in Eq. (1); n is the
number of binding sites per albumin molecule; K is bindingconstant of indigotin with BSA/HSA. The binding constant
(K) and the number of binding sites (n) could be calculated by
plotting log [(F0F)/F] versus log [Q] as shown in Fig. 5. From
the slope (n) and the intercept (log K) of the linear ﬁtting plots,
the binding constant K values are calculated and are listed in
Table 3. As could be seen in Table 3, the binding constants
calculated for indigotin–BSA/HSA systems suggested low
binding afﬁnity compared to other strong protein–ligand
complexes with binding constants ranging from 106 to108 M1
[23,24]. However, lower binding constants (103–104 M1) were
also reported in several other ligand-protein complexes using
ﬂuorescence spectroscopic methods [25–27]. In addition, the
binding constants (K) increased with increasing temperature,
which indicated that the stability of the indigotin–BSA
and indigotin–HSA complexes would decrease. The correla-
tion coefﬁcients (R) were larger than 0.9960, suggesting that
assumptions underlying the derivation of Eq. (4) were reason-
able. It could be inferred from the values of n that there
was about one independent class of the binding site on
BSA/HSA in the presence of indigotin. HSA has one trypto-
phan residue (Trp-214) in subdomain IIA, whereas BSA has
Table 3 The binding constants K, the number of binding sites n, and the thermodynamic parameters of the indigotin–BSA/HSA
systems at four temperatures.
System T (K) K 105 (L/mol) n Ra DG (kJ/mol) DH (kJ/mol) DS (kJ/mol K) Rb
BSA–indigotin 293 1.851 1.05 0.9996 29.402 43.642 0.249 0.9904
298 2.186 1.07 0.9978 30.648
304 3.279 1.11 0.9962 32.144
310 4.827 1.15 0.9990 33.640
HSA–indigotin 293 4.824 1.13 0.9963 31.965 18.573 0.172 0.9775
298 6.005 1.15 0.9991 32.827
304 6.518 1.17 0.9985 33.862
310 7.513 1.21 0.9995 34.897
aThe correlation coefﬁcient for K values.
bThe correlation coefﬁcient for the Van’t Hoff plot.
Fig. 6 Van’t Hoff plots for the BSA–indigotin and HSA–
indigotin systems in Tris–HCl buffer, pH¼7.4.
Z.-J. Cheng et al.262two tryptophan residues (Trp-134 and Trp-212). Trp-134
residue is embedded in the subdomain IB and it is more
exposed to a hydrophilic environment, and Trp-212 residue is
embedded in subdomain IIA and it is deeply buried in the
hydrophobic loop. Such, indigotin most likely bind to the
hydrophobic pocket located in subdomain IIA [28]. Whereas,
larger number of bound lipid (n) was reported for HSA with
DDAB (n¼1.82), DOTAP (n¼1.56), and DOPE (n¼1.76)
[29].
The interactions between small molecules and macromole-
cules usually follow four binding forces: hydrogen bond,
van der Waals, electrostatic and hydrophobic force. The binding
studies were carried out at 293, 298, 304 and 310 K. At these
temperatures, BSA and HSA do not undergo any structural
change. In order to characterize the forces between indigotin
and BSA/HSA, the thermodynamic parameters on four tem-
peratures were analyzed by the Van’t Hoff equation [30]:
ln K ¼DH
RT
þ DS
R
ð5Þ
DG¼ DHTDS¼RT ln K ð6Þ
K is the equilibrium binding constant (L/mol), T is absolute
temperature and R is the gas constant (8.314 J/(mol K)).According to the binding constants of indigotin–BSA/HSA
systems obtained at the four temperatures mentioned earlier,
the corresponding values of DH and DS can be obtained from
the linear relationship between ln K and the reciprocal absolute
temperature (Fig. 6), and the DG values can be calculated by Eq.
(6). The values of DH, DS and DG are summarized in Table 3.
As shown in Table 3, the negative values of DG indicated that
the binding interactions of indigotin to BSA/HSA were sponta-
neous processes. The positive DH and DS values suggested that
the indigotin–BSA/HSA complexes were formed by the hydro-
phobic interaction [31].3.4. Identiﬁcation of binding sites on BSA/HSA
In order to further identify the binding sites on BSA/HSA by
indigotin, the site marker competitive experiments are per-
formed using the drugs speciﬁcally bind to a know site or
region on BSA/HSA. The proteins (BSA and HSA) consist of
three homologous domains (I–III), and each domain contains
two subdomains (A and B). The binding sites of endogenous
or exogenous ligands to BSA/HSA may be in these domains,
and the principal regions of the binding sites of proteins are
located in hydrophobic cavities in subdomains IIA or IIIA.
Moreover, many ligands could bind speciﬁcally to HSA/BSA,
for example, phenylbutazone and warfarin for site I, ibuprofen
and ﬂufenamic acid for site II, and digitoxin for site III [32]. In
the study, the site probes, viz. phenylbutazone, ibuprofen and
digitoxin were chosen to identify the binding site on BSA/HSA
by indigotin. The ﬂuorescence spectra of the ternary mixtures
(indigotin- proteins-the site probe) were recorded in the range
of 250–500 nm. That is to say, the solution of indigotin was
gradually titrated to the system of BSA/HSA with the site
marker and the concentration of BSA/HSA to the site marker
was kept at 1:1. Then, the ﬂuorescence quenching data were
analyzed using Eq. (4), and the values of K and R are listed in
Table 4. As shown in Table 4, the binding constants of
indigotin–BSA/HSA systems remarkably decreased in the
presence of phenylbutazone (PB), whereas with the addition
of ibuprofen (IB) or digitoxin (DIG) resulted in only a small
difference. The results indicated that the binding sites of
indigotin to BSA/HSA mainly located within site I (subdo-
main IIA), suggesting that the involvement of hydrophobic
interaction played a major role in the binding reaction
Table 4 Effects of the site probe on the binding constants of indigotin to BSA/HSA.
System Without With IB With PB With DIG
K ( 105 L/mol) R K ( 105 L/mol) R K ( 105 L/mol) R K( 105 L/mol) R
BSA–indigotin 2.186 0.9978 3.318 0.9994 1.585 0.9991 2.915 0.9996
HSA–indigotin 6.005 0.9991 6.167 0.9990 1.922 0.9979 4.858 0.9989
Fig. 7 The spectral overlap of UV–vis absorption spectrum of indigotin and ﬂuorescence emission spectra of BSA (A) and HSA (B); (a)
ﬂuorescence emission spectrum of BSA; (b) UV–vis absorption spectrum of indigotin; and (c) ﬂuorescence emission spectrum of HSA.
c(BSA)¼c(HSA)¼5.0 mM, c(indigotin)¼5.0 mM, T¼298 K.
Table 5 The energy transfer parameters between indigotin and BSA/HSA.
System J (cm3 L/mol) E R0 (nm) r (nm)
BSA–indigotin 9.847 10-15 0.310 2.514 2.873
HSA–indigotin 9.920 10-15 0.306 2.517 2.885
Investigation of interaction between indigotin and serum albumins 263between indigotin and BSA/HSA. Obviously, the above results
were in good agreement with those obtained by the binding
parameters and binding interaction forces of BSA/HSA with
indigotin studies.
3.5. Energy transfer between indigotin and BSA/HSA
The distance between BSA/HSA and indigotin can be calcu-
lated by Fo¨ster’s non-radiative energy transfer theory [33].
According to the theory, the efﬁciency of energy transfer is
inﬂuenced by the distance between acceptor and donor, and
the critical energy transfer distance is calculated using Eq. (7)
and the value of R0 is obtained by Eq. (8)
E ¼ 1F=F0 ¼R60=ðR60 þ r6Þ ð7Þ
R60 ¼ 8:8 1025k2n4UJ ð8Þ
In the above experiment conditions, k2¼2/3, n¼1.36,
F¼0.15 for BSA [34] and k2¼2/3, n¼1.336, F¼0.118 for
HSA [35]. The value of J can be calculated by the followingequation:
J ¼
X
FðlÞeðlÞl4Dl=
X
FðlÞDl ð9Þ
The overlap of UV–vis absorption spectrum of indigotin and
ﬂuorescence emission spectra of BSA and HSA are shown in
Fig. 7.
According to Eqs.(7–9) and the experimental data, the J, E,
R0 and r values of the binding interaction between indigotin
and BSA/HSA are obtained and listed in Table 5. As shown in
Table 5, the average distance of indigotin to BSA/HSA was
shorter than 8 nm, suggesting that the non-radiative energy
transfer from BSA/HSA to indigotin occurred with high
probability and the result (R0or) reconﬁrmed the presence
of the static quenching interaction between indigotin and
BSA/HSA [36]. Moreover, the binding distance of indigotin
to proteins was shorter than those of ribavirin to BSA/HSA
(5.43 nm/3.74 nm) [37], which indicated that the binding
afﬁnity of indigotin–proteins complexes was higher than that
of ribavirin-BSA/HSA complexes. The result was consistent
with their ﬂuorescence spectra data studies [38,39].
Z.-J. Cheng et al.2643.6. The inﬂuence of indigotin on the conformation BSA/HSA
In order to explore the structural change of BSA/HSA in the
presence of indigotin, synchronous ﬂuorescence, three-
dimensional ﬂuorescence, FT-IR and CD spectra of BSA/
HSA before and after the addition of indigotin were analyzed,
respectively.3.6.1. Synchronous ﬂuorescence spectroscopy studies
Synchronous ﬂuorescence spectrum is a useful method to
evaluate the conformational changes of proteins. The shift in
position of emission maximum reﬂects the change of the polarity
around the chromophore molecule, thus the microenvironment
of amino acid residues (such as tryptophan, tyrosine, etc.) can be
studied by measuring the possible shift in maximum emission
wavelength. When the wavelength interval (Dl) between the
excitation and emission wavelength is stabilized at 15 and
60 nm, the synchronous ﬂuorescence spectra offer the character-
istics of tyrosine and tryptophan residues, respectively. The
ﬂuorescence spectra of BSA/HSA with various amounts of
indigotin are recorded at Dl¼15 nm and Dl¼60 nm and are
shown in Fig. 8.
It was apparent from Fig. 8(A, a) and (B, a) that the
emission intensities of tyrosine residues decreased and the
emission maximum wavelength slightly shifted towards shortFig. 8 Synchronous ﬂuorescence spectra of (A) BSA and (B) HSA
Dl¼60 nm (b), [BSA]¼ [HSA]¼5.0 mM, Cindigotin (16)¼0.0, 4.0, 8.0wavelength (from 286 to 284 nm), indicating that the interac-
tion of indigotin with BSA/HSA affected the conformation of
the region around tyrosine residues. In Fig. 8(A, b) and (B, b),
the emission maximum wavelength of tryptophan residues
showed slight blue shifts (from 280 to 278 nm) with the
addition of indigotin, which suggested that the hydrophobicity
around tryptophan residues increased and the polarity around
tryptophan residues decreased. The above results implied that
indigotin was closer to tryptophan residues than tyrosine
residues, namely the binding sites mainly were focused on
tryptophan moiety. The result was consistent with the result of
the displacement experiments.3.6.2. Three-dimensional ﬂuorescence spectra studies
Because three-dimensional ﬂuorescence spectroscopy can pro-
vide more detailed information about the conformational
changes of proteins, it has become a popular ﬂuorescence
analysis technique in recent years [40]. The excitation wave-
length, emission wavelength and ﬂuorescence intensity can be
used as axes in the ﬂuorescence emission spectra. The max-
imum emission wavelength and ﬂuorescence intensity of the
residues (such as tryptophan and tyrosine) show a close
relation to the polarities of their microenvironment. Fig. 9
shows the 3D ﬂuorescence spectra for BSA, indigotin–BSA
complex, HSA and indigotin–HSA complex, and thewith different concentrations of indigotin at Dl¼15 nm (a) and
, 12.0, 16.0 and 20.0 mM. T¼298 K.
Fig. 9 Three-dimensional ﬂuorescence spectra of BSA (1), BSA–indigotin system (2), HSA (3), and HSA–indigotin system (4);
conditions: c(BSA)¼c(HSA)¼5.0 mM, c(indigotin)¼16.0 mM, pH¼7.4, T¼298 K.
Table 6 Three-dimensional ﬂuorescence characteristic parameters of SA and the indigotin–SA systems.
Peak SA SA–indigotin
Peak position lex/lem (nm/nm) Intensity F0 Peak position lex/lem (nm/nm) Intensity F0 F/F0
BSA A 300/300 116.5 300/300 94.79
I 282/340 697.6 282/340 233.5 0.335
II 232/335 261.5 232/335 96.5 0.369
B 248/495 156.6 248/495 88.9
HSA
A 300/330 108.7 330/330 135.4
I 282/340 735.8 282/335 293.4 0.372
II 238/340 232.2 236/345 108.8 0.469
B 248/495 161.7 248/495 106.8
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listed in Table 6.
Four peaks can be seen in the 3D ﬂuorescence spectra
(Fig. 9). The peak at the left (Peak A) is the ﬁrst-ordered
Rayleigh scattering peak, whose emission wavelength equals
the excitation wavelength, whereas the peak at the right (Peak
B) is the second-ordered Rayleigh scattering peak, whose
emission wavelength is two times as the excitation. The
ﬂuorescence intensity of peak A increased with the addition
of indigotin. It could be attributed to indigotin–HSA complexthat made the volume of HSA increased, which in turn
resulted in the enhancement of the scattering effect.
There are two strong ﬂuorescence peaks seen in the middle
of Fig. 9, Peak I mainly reﬂects the spectral behavior of
tryptophan and tyrosine residues on BSA/HSA; Peak II shows
the behavior of polypeptide backbone structures of BSA/HSA
and its intensity is correlated with the secondary structures of
proteins [41]. The ﬂuorescence intensities of Peak I and II for
the indigotin–BSA complex have been quenching about 66.5%
and 63.1% (Table 6); for the indigotin–HSA complex, its Peak
Z.-J. Cheng et al.266I and II have been quenching about 62.8% and 53.1%,
moreover, their corresponding maximum emission wavelength
slightly blue shifted (from 340 to 335 nm) and red shifted
(from 340 to 345 nm), respectively. This indicated that the
interactions between indigotin and proteins induced a slight
unfolding of the polypeptide backbone in BSA/HSA, and
indigotin would locate at the vicinity of tryptophan residues
on BSA/HSA. The results were in accordance with those
obtained by the synchronous ﬂuorescence spectra, site marker
competitive experiments and CD spectra studies.
3.6.3. FT-IR spectra studies
The interactions between indigotin and BSA/HSA were
characterized by infrared spectroscopy. Because there was
no major spectral shifting for BSA/HSA amide I band at
1656/1655 cm1 (mainly CQO stretch) and amide II band at
1548/1547 cm1 (C–N stretching coupled with N–H bending
modes) in the presence of indigotin, the difference spectra
[(protein solutionþindigotin solution)(protein solution)] were
obtained in order to monitor the intensity changes of these
vibrations, and their results are shown in Figs. 10 and 11.
When the molar ratio of HSA/BSA to indigotin was
maintained at 1:3, the intensity changes were observed for
BSA/HSA amide I band at 1650/1654 cm1 and amide II band
at 1547/1549 cm1, and negative features were observed in the
difference spectra for the amide I and II bands at 1659 and
1547 cm1 (BSA), 1655 and 1547 cm1 (HSA) in the BSA–
indigotin and HSA–indigotin systems, respectively (Figs. 10
and 11). For the BSA–indigotin and HSA–indigotin com-
plexes, the intensities of the amide I band of BSA/HSA at
1656/1655 cm1 decreased, which suggested that the percen-
tage content of a-helical structure of proteins would decrease
at high indigotin concentration [42–44]. The results were in
accordance with the CD spectra data analysis.
3.6.4. CD spectra studies
Circular dichroism (CD) is an important technique in the
structural characterization of proteins, and especially for
secondary structure determination. Thus, in the current study,
the CD method has been applied to monitor the secondary
structural change of proteins upon interaction with ligands.
The CD spectra of BSA/HSA in the absence and presence of
indigotin are shown in Fig. 12. As shown in Fig. 12, proteinsFig. 10 FT-IR spectra in the region of 1800–900 cm1 for free BSA
indigotin was maintained at 1:3), and its corresponding difference sp
subtracted from different spectra in this region.exhibited two negative ellipticities at 208 and 220 nm in the
UV region, which were characteristic of the typical a-helix
structure of proteins. The CD results are expressed in terms of
mean residue ellipticity (MRE) by the following equation [5]:
MRE ¼ Observed CD ðmdeg:Þ
Cpnl  10
ð10Þ
where Cp is the molar concentration of protein, n is the
number of amino acid residues and l is the path length. The
a-helix contents of free and combined BSA and HSA are
calculated from MRE values at 208 nm using the equation [5]:
a-helix ð%Þ ¼ ½ðMRE2084000Þ  100=ð330004000Þ ð11Þ
in Eq. (11), MRE208 represents the observed MRE value at
208 nm, 4000 is theMER value of the b-form and random-coil
conformation cross at 208 nm, and 33000 is the MER value of
a pure a-helix at 208 nm. According to the above equations,
the a-helix content of BSA and HSA was calculated. It
decreased from 51.7% in free BSA to 46.9% in indigotin–
BSA, and from 57.0% in free HSA to 44.3% in indigotin–
HSA. The decrease of a-helix contents indicated that indigotin
bound to the amino acid residues of the main polypeptide
chain of BSA/HSA and destroyed the hydrogen-networks [9].
Furthermore, the CD spectra of BSA/HSA in the presence and
absence of indigotin were observed to be similar in shape,
indicating that the structure of proteins was also predomi-
nantly a-helical even after binding to indigotin [5]. So, we
believed that the binding between indigotin and BSA/HSA
induced the structural change of proteins.3.7. Hydrophobic interactions
In order to examine the hydrophobic contact in the BSA–
indigotin and HSA–indigotin complexes, the antisymmetric and
symmetric CH2 stretching vibrations of proteins [44] were
Investigated in the region 2800–3000 cm1. The CH2 bands of
free BSA located at 2961, 2932 and 2861 cm1 shifted to 2956,
2924 and 2854 cm1 (indigotin), and yet, the CH2 bands of free
HSA located at 2938 and 2874 cm1 shifted to 2917 and
2880 cm1 (indigotin) in the protein-dye complexes (Fig. 13).
So, the antisymmetric and symmetric CH2 stretching vibrations
of proteins shifted. The results indicated that the indigotin–BSA/
HSA complexes were formed by the hydrophobic interaction(0.10 mM), the BSA–indigotin complex (the molar ratio of BSA/
ectra (indicated in the ﬁgure). The contribution of indigotin was
Fig. 11 FT-IR spectra in the region of 1800–900 cm1 for free HSA (0.10 mM), the HSA–indigotin complex (the molar ratio of HSA/
indigotin was maintained at 1:3), and its corresponding difference spectra (indicated in the ﬁgure). The contribution of indigotin was
subtracted from different spectra in this region.
Fig. 12 CD spectra of BSA (A) and HSA (B) by indigotin. Conditions: c(BSA)¼c(HSA)¼1.0 mM; c(indigotin) a–c, 0, 10.00, 20.00 mM.
Fig. 13 Infrared spectra of proteins CH2 symmetric and antisymmetric stretching vibrations and indigotin–BSA/HSA complexes in the
region 3000–2800 cm1, the contribution of the CH2 stretching vibrations of indigotin was subtracted in the region.
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scopic results discussed above.4. Conclusions
In this paper, we have investigated the binding interactions of
proteins with indigotin at simulative physiological condition
using various methods. The experimental results showed that
indigotin could bind to SAs to form a indigotin–SA complex
with one binding site. From the thermodynamic parameters
calculation, it suggested that the indigotin–SAs complexes
were formed by the hydrophobic interaction force. The results
of synchronous ﬂuorescence, 3D ﬂuorescence and CD spectra
indicated that the microenvironment of tyrosine and trypto-
phan residues on proteins altered with the addition of
indigotin. The study would be useful for understanding the
biological effects and functions of dyes in the body. In
addition, the comparisons of binding afﬁnity between SAs
and indigotin derivatives or other azo dyes are worthy to be
explored in the future because they are likely to provide useful
information for studying their toxicity at the functional
macromolecular level.
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